Skip to main content

Advertisement

SpringerLink
Log in

Global epidemiology of hcv infection

  • Published:
Current Hepatitis Reports Aims and scope Submit manuscript

Abstract

The prevalence of hepatitis C virus (HCV) infection is estimated to be 3% worldwide. Regional variation is related to differences in risk factors, health care practices, economic issues, and societal norms. In recent years, blood screening programs and improved public awareness have led to a reduction in new cases of HCV in western countries. Despite these advances, new infections continue to occur, particularly in the developing world. An understanding of the global epidemiology of HCV provides the basis for generating public health initiatives to address this growing problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium [no authors listed]. J Viral Hepat 1999, 6:35–47.

    Article  Google Scholar 

  2. World Health Organization: Global distribution of hepatitis A, B, and C, 2001 [no authors listed]. Wkly Epidemiol Rec 2002, 77:45.

    Google Scholar 

  3. Wasley A, Alter MJ: Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000, 20:1–16.

    Article  PubMed  CAS  Google Scholar 

  4. Alter MJ: Hepatitis C: fact vs fiction. In Viral Hepatitis and Liver Disease. Edited by Margolis HS, et al. Atlanta, GA: International Medical Press; 2002:310–315.

    Google Scholar 

  5. Thorpe LE, Ouellet LJ, Levy JR, et al.: Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997–1999. J Infect Dis 2000, 182:1588–1594.

    Article  PubMed  CAS  Google Scholar 

  6. Ansaldi F, Bruzzone B, Salmaso S, et al.: Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol 2005, 76:327–332.

    Article  PubMed  CAS  Google Scholar 

  7. Tanaka H, Hiyama T, Tsukuma H, et al.: Prevalence of second generation antibody to hepatitis C virus among voluntary blood donors in Osaka, Japan. Cancer Causes Control 1994, 5:409–413.

    Article  PubMed  CAS  Google Scholar 

  8. Silini E, Bono F, Cividini A, et al.: Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J Hepatol 1995, 22:691–695.

    Article  PubMed  CAS  Google Scholar 

  9. Alter MJ, Kruszon-Moran D, Nainan OV, et al.: The prevalence of hepatitis C infection in the United States, 1988 through 1994. N Engl J Med 1999, 341:556–562. This is a large population-based study that evaluated serum samples from persons who participated in the NHANES III. The study defined the prevalence of HCV in the U.S.

    Article  PubMed  CAS  Google Scholar 

  10. Tedder RS, Briggs M, Ring C, et al.: Hepatitis C antibody profile and viraemia prevalence in adults with severe haemophilia. Br J Haematol 1991, 79:512–515.

    PubMed  CAS  Google Scholar 

  11. Goedert JJ, Brown DL, Hoots K, Sherman KE: Human immunodeficiency and hepatitis virus infections and their associated conditions and treatments among people with haemophilia. Haemophilia 2004, 10(suppl 4):205–210.

    Article  PubMed  Google Scholar 

  12. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ: The risk of transfusion-transmitted viral infections. N Engl J Med 1996, 334:1685–1690.

    Article  PubMed  CAS  Google Scholar 

  13. Luby SP, Qamruddin K, Shah AA, et al.: The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol Infect 1997, 119:349–356.

    Article  PubMed  CAS  Google Scholar 

  14. Hauri AM, Armstrong GL, Hutin YJ: The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS 2004, 15:7–16.

    Article  PubMed  Google Scholar 

  15. Ishikawa T, Fukushima Y, Shiobara Y, et al.: Outbreak of hepatitis C virus infection in an outpatient clinic. J Gastroenterol Hepatol 2005, 20:1087–1093.

    Article  PubMed  Google Scholar 

  16. Fissell RB, Bragg-Gresham JL, Woods JD, et al.: Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2004, 65:2335–2342.

    Article  PubMed  Google Scholar 

  17. Thomas DL, Zenilman JM, Alter HJ, et al.: Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore. An analysis of 309 sex partnerships. J Infect Dis 1995, 171:768–775.

    PubMed  CAS  Google Scholar 

  18. Tahan V, Karaca C, Yildirim B, et al.: Sexual transmission of HCV between spouses. Am J Gastroenterol 2005, 100:821–824.

    Article  PubMed  Google Scholar 

  19. Haley RW, Fischer RP: The tattooing paradox: are studies of acute hepatitis adequate to identify routes of transmission of subclinical hepatitis C infection? Arch Intern Med 2003, 163:1095–1098.

    Article  PubMed  Google Scholar 

  20. Chandra M, Khaja MN, Farees N, et al.: Prevalence, risk factors and genotype distribution of HCV and HBV infection in the tribal population: a community based study in south India. Trop Gastroenterol 2003, 24:193–195.

    PubMed  Google Scholar 

  21. Roberts EA, Yeung L: Maternal-infant transmission of hepatitis C virus infection. Hepatology 2002, 36(5 suppl 1): S106-S113.

    Article  PubMed  Google Scholar 

  22. Zanetti AR, Tanzi E, Romano L, et al.: A prospective study on mother-to-infant transmission of hepatitis C virus. Intervirology 1998, 41:208–212.

    Article  PubMed  CAS  Google Scholar 

  23. Tajiri H, Miyoshi Y, Funada S, et al.: Prospective study of mother-to-infant transmission of hepatitis C virus. Pediatr Infect Dis J 2001, 20:10–14.

    Article  PubMed  CAS  Google Scholar 

  24. Ceci O, Margiotta M, Marello F, et al.: Vertical transmission of hepatitis C virus in a cohort of 2,447 HIV-seronegative pregnant women: a 24-month prospective study. J Pediatr Gastroenterol Nutr 2001, 33:570–575.

    Article  PubMed  CAS  Google Scholar 

  25. National Institutes of Health Consensus Development Conference Panel Statement. Management of hepatitis C [no authors listed]. Hepatology 1997, 26(suppl 1):2S-10S.

    Google Scholar 

  26. Wong JB, McQuillan GM, McHutchison JG, Poynard T: Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000, 90:1562–1569. Using data from NHANES III, this study modeled the future costs, morbidity, and mortality of HCV in the U.S. The findings suggested that despite the decline in the incidence of HCV, mortality and economic costs related to hepatitis C will continue to increase over the next 10 to 20 years.

    PubMed  CAS  Google Scholar 

  27. Manuel DG, Johnson I, Fearon M, Hockin J: The prevalence of hepatitis C in a community based population, Ontario, 1996. Can Commun Dis Rep 1999, 25:193–199.

    PubMed  CAS  Google Scholar 

  28. Andonov A, Chaudhary RK: Genotyping of Canadian hepatitis C virus isolates by PCR. J Clin Microbiol 1994, 32:2031–2034.

    PubMed  CAS  Google Scholar 

  29. Minuk GY, Zhang M, Wong SG, et al.: Viral hepatitis in a Canadian First Nations community. Can J Gastroenterol 2003, 17:593–596.

    PubMed  CAS  Google Scholar 

  30. Minuk GY, Uhanova J: Viral hepatitis in the Canadian Inuit and First Nations populations. Can J Gastroenterol 2003, 17:707–712.

    PubMed  Google Scholar 

  31. Touzet S, Kraemer L, Colin C, et al.: Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature. HENCORE Group. (Hepatitis C European Network for Co-operative Research. Eur J Gastroenterol Hepatol 2000, 12:667–678.

    Article  PubMed  CAS  Google Scholar 

  32. Balogun MA, Ramsay ME, Hesketh LM, et al.: The prevalence of hepatitis C in England and Wales. J Infect 2002, 45:219–226.

    Article  PubMed  CAS  Google Scholar 

  33. Harris KA, Gilham C, Mortimer PP, Teo CG: The most prevalent hepatitis C virus genotypes in England and Wales are 3a and 1a. J Med Virol 1999, 58:131–137.

    Article  Google Scholar 

  34. Dubois F, Desenclos JC, Mariotte N, Goudeau A: Hepatitis C in a French population survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. Hepatology 1997, 25:1490–1496.

    Article  PubMed  CAS  Google Scholar 

  35. Payan C, Roudot-Thoraval F, Marcellin P, et al.: Changing of hepatitis C virus genotype patterns in France at the beginning of the third millennium: the GEMHEP GenoCII Study. J Viral Hepat 2005, 12:405–413.

    Article  PubMed  CAS  Google Scholar 

  36. Deuffic S, Buffat L, Poynard T, Valleron AJ: Modeling the hepatitis C virus epidemic in France. Hepatology 1999, 29:1596–1601.

    Article  PubMed  CAS  Google Scholar 

  37. Palitzsch KD, Hottenträger B, Schlottmann K, et al.: Prevalence of antibodies against hepatitis C virus in the adult German population. Eur J Gastroenterol Hepatol 1999, 11:1215–1220.

    Article  PubMed  CAS  Google Scholar 

  38. Berg T, Hopf U, Stark K, et al.: Distribution of hepatitis C virus genotypes in German patients with chronic hepatitis C: correlation with clinical and virological parameters. J Hepatol 1997, 26:484–491.

    Article  PubMed  CAS  Google Scholar 

  39. Riestra S, Fernandez E, Leiva P, et al.: Prevalence of hepatitis C virus infection in the general population of northern Spain. Eur J Gastroenterol Hepatol 2001, 13:477–481.

    Article  PubMed  CAS  Google Scholar 

  40. Muller Z, Deak J, Horanyi M, et al.: The detection of hepatitis C virus in South Hungary. J Clin Virol 2001, 20:81–83.

    Article  PubMed  CAS  Google Scholar 

  41. Ambrozaitis AZ, Agminas KS, Balc Iunaite G, Widell A: Hepatitis C in Lithuania: incidence, prevalence, risk factors and viral genotypes. Clin Diagn Virol 1995, 4:273–284.

    Article  PubMed  CAS  Google Scholar 

  42. Kurbanov F, Tanaka Y, Sugauchi F, et al.: Hepatitis C virus molecular epidemiology in Uzbekistan. J Med Virol 2003, 69:367–375.

    Article  PubMed  CAS  Google Scholar 

  43. Brojer E, Gronowska A, Medynska J, et al.: The hepatitis C virus genotype and subtype frequency in hepatitis C virus RNApositive, hepatitis C virus antibody-negative blood donors identified in the nucleic acid test screening program in Poland. Transfusion 2004, 44:1706–1710.

    Article  PubMed  CAS  Google Scholar 

  44. Viazov S, Kuzin S, Paladi N, et al.: Hepatitis C virus genotypes in different regions of the former Soviet Union (Russia, Belarus, Moldova, and Uzbekistan). J Med Virol 1997, 53:36–40.

    Article  PubMed  CAS  Google Scholar 

  45. Amin J, Gidding H, Gilbert G, et al.: Hepatitis C prevalence—a nationwide serosurvey. Commun Dis Intell 2004, 28:517–521.

    PubMed  Google Scholar 

  46. Robotin MC, Copland J, Tallis G, et al.: Surveillance for newly acquired hepatitis C in Australia. J Gastroenterol Hepatol 2004, 19:283–288.

    Article  PubMed  Google Scholar 

  47. Hayashi J, Kishihara Y, Yamaji K, et al.: Transmission of hepatitis C virus by health care workers in a rural area of Japan. Am J Gastroenterol 1995, 90:794–799.

    PubMed  CAS  Google Scholar 

  48. Vital Statistics of Japan 2001. In Statistics and Information Department, Minister’s Secretariat, Ministry of Health, Labor and Welfare. Health and Welfare Statistics Association, Tokyo: Ohwa Sogo Insatsu. Co; 2003.

  49. Chowdhury A, Santra A, Chaudhuri S, et al.: Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology 2003, 37:802–809.

    Article  PubMed  Google Scholar 

  50. Phukan AC, Sharma SK, Das HK, Mahanta J: HCV activity in an isolated community in north east India. Indian J Pathol Microbiol 2001, 44:403–405.

    PubMed  CAS  Google Scholar 

  51. Raghuraman S, Shaji RV, Sridharan G, et al.: Distribution of the different genotypes of HCV among patients attending a tertiary care hospital in south India. J Clin Virol 2003, 26:61–69.

    Article  PubMed  Google Scholar 

  52. Aslam M, Aslam J: Seroprevalence of the antibody to hepatitis C in select groups in the Punjab region of Pakistan. J Clin Gastroenterol 2001, 33:407–411.

    Article  PubMed  CAS  Google Scholar 

  53. Aslam M, Aslam J, Mitchell BD, Munir KM: Association between smallpox vaccination and hepatitis C antibody positive serology in Pakistani volunteers. J Clin Gastroenterol 2005, 39:243–246.

    Article  PubMed  Google Scholar 

  54. Madhava V, Burgess C, Drucker E: Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2002, 2:293–302.

    Article  PubMed  Google Scholar 

  55. Candotti D, Temple J, Sarkodie F, Allain JP: Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. J Virol 2003, 77:7914–7923.

    Article  PubMed  CAS  Google Scholar 

  56. Abdel-Aziz F, Habib M, Mohamed MK, et al.: Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology 2000, 32:111–115.

    Article  PubMed  CAS  Google Scholar 

  57. Delaporte E, Thiers V, Dazza M, et al.: High level of hepatitis C endemicity in Gabon, equatorial Africa. Trans R Soc Trop Med Hyg 1993, 87:636–637.

    Article  PubMed  CAS  Google Scholar 

  58. Njouom R, Pasquier C, Ayouba A, et al.: High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon. J Med Virol 2003, 71:219–225.

    Article  PubMed  Google Scholar 

  59. el-Sadawy M, Ragab H, el-Toukhy H, et al.: Hepatitis C virus infection at Sharkia Governorate, Egypt: seroprevalence and associated risk factors. J Egypt Soc Parasitol 2004, 34(suppl 1):367–384.

    PubMed  Google Scholar 

  60. Ray SC, Arthur RR, Carella A, et al.: Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 2000, 182:698–707.

    Article  PubMed  CAS  Google Scholar 

  61. Yoshizawa H: Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future. Oncology 2002, 62:8–17.

    Article  PubMed  Google Scholar 

  62. El-Serag HB, Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999, 340:745–750.

    Article  PubMed  CAS  Google Scholar 

  63. Tanaka Y, Hanada K, Mizokami M, et al.: Inaugural Article: A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci U S A 2002, 99:15584–15589. By using molecularly clocked long-term serial samples, the investigators estimated when HCV appeared and spread in Japan and the U.S. These analyses indicate that both the divergence time and the spread time for HCV in Japan occurred decades before these same events in the U.S. Assuming the differing HCC prevalence in the U.S. and Japan reflects the longer duration of the epidemic in Japan, it was predicted there will be an increase in the disease burden of HCC in the U.S. in the coming decades.

    Article  PubMed  CAS  Google Scholar 

  64. Sandler RS, Everhart JE, Donowitz M, et al.: The burden of selected digestive diseases in the United States. Gastroenterology 2002, 122:1500–1511.

    Article  PubMed  Google Scholar 

  65. El Saadany S, Coyle D, Giulivi A, Afzal M: Economic burden of hepatitis C in Canada and the potential impact of prevention Results from a disease model. Eur J Health Econ 2005, 6:159–165.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Illinois at Chicago, Section of Hepatology (MC 716), Room 718-E, Clinical Sciences Building, 840 South Wood Street, 60612-7323, Chicago, IL, USA

    Jamie Berkes MD

Authors
  1. Jamie Berkes MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Scott J. Cotler MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berkes, J., Cotler, S.J. Global epidemiology of hcv infection. Curr hepatitis rep 4, 125–130 (2005). https://doi.org/10.1007/s11901-005-0027-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11901-005-0027-z

Keywords

Search

Navigation